Logo for Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Investor Relations Material

Latest events

Logo for Hepion Pharmaceuticals

Q3 2024

14 Nov, 2024
Logo for Hepion Pharmaceuticals

Q2 2024

13 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Hepion Pharmaceuticals Inc

Access all reports
Hepion Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for liver diseases, particularly non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company’s lead drug candidate, based on cyclophilin inhibition technology, aims to target inflammation, fibrosis, and viral infections affecting the liver. The company is headquartered in Edison, New Jersey, and its shares are listed on the NASDAQ.